Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Special Issue: Current evidence and perspectives for hypertension management in Asia
  • Published:

Prevalence of true resistant hypertension in those referred for uncontrolled hypertension in Malaysia: A comparison using different definitions

Abstract

Resistant hypertension is a well-recognised clinical challenge. However, the definition and epidemiology of true resistant hypertension (RH) are less understood, especially in Asia. This cross-sectional study examined the prevalence of RH referred from primary care clinics based on various guidelines. RH was defined as blood pressure (BP) being above the threshold using ambulatory blood pressure monitoring despite adequate lifestyle measures and optimal treatment with ≥3 medications at maximally tolerated doses. Between one in four (n = 94, 24.0% using Malaysian guidelines) and up to two-thirds (n = 249, 63.7% using 2018 American guidelines) of adults referred for uncontrolled hypertension met the criteria of true RH. Of those with RH, a further one-quarter (n = 26, 26.6%) were deemed to have refractory hypertension (elevated BP despite treatment with at least 5 antihypertensive medications). Adults with RH were generally younger, more likely to be male, had a higher BMI and were more likely to have gout, CKD, and angina compared to those with controlled hypertension. The prevalence of RH amongst Asian adults with poor hypertension control is high. A concerted effort is needed to reduce the high burden of RH, especially among this population.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. de Jager RL, van Maarseveen EM, Bots ML, Blankestijn PJ, investigators S. Medication adherence in patients with apparent resistant hypertension: findings from the SYMPATHY trial. Br J Clin Pharmacol. 2018;84:18–24.

    Article  PubMed  Google Scholar 

  2. Chia YC, Ching SM. Prevalence and predictors of resistant hypertension in a primary care setting: a cross-sectional study. BMC Fam Pr. 2014;15:131.

    Article  Google Scholar 

  3. Kario K, Tomitani N, Buranakitjaroen P, Chia YC, Park S, Chen CH, et al. Home blood pressure control status in 2017‐2018 for hypertension specialist centers in Asia: results of the Asia BP@ Home study. The. J Clin Hypertens. 2018;20:1686–95.

    Article  Google Scholar 

  4. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. International society of hypertension global hypertension practice guidelines. Hypertension. 2020;75:1334–57.

    Article  PubMed  CAS  Google Scholar 

  5. Noubiap JJ, Nansseu JR, Nyaga UF, Sime PS, Francis I, Bigna JJ. Global prevalence of resistant hypertension: a meta-analysis of data from 3.2 million patients. Heart 2019;105:98.

    Article  PubMed  Google Scholar 

  6. Clinical Practice Guidelines: Management of Hypertension. In. Vol 5th edition. Ministry of Health Malaysia: Putrajaya, 2018.

  7. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. ESC/ESH Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39:3021–104.

    Article  PubMed  Google Scholar 

  8. Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Hypertension .2018;71:1269–324.

    Article  PubMed  CAS  Google Scholar 

  9. Vaduganathan M, Mensah George A, Turco Justine V, Fuster V, Roth, Gregory A. The global burden of cardiovascular diseases and risk. J Am Coll Cardiol. 2022;80:2361–71.

    Article  PubMed  Google Scholar 

  10. Huang H-C, Cheng H-M, Chia Y-C, Li Y, Van Minh H, Siddique S, et al. The role of renal nerve stimulation in percutaneous renal denervation for hypertension: a mini-review. J Clin Hypertens. 2022;24:1187–93.

    Article  Google Scholar 

  11. Kario K, Chia YC, Wang JG. The HOPE Asia Network activity 2022: towards better hypertension management in Asia. J Clin Hypertens (Greenwich). 2022;24:1109–11.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors wish to thank Ang KL, Lim SR, Lee V, Lai YLC, Chieng MCH, Lim SH, Yunos NE, Parveen R and staff from Clinical Research Center, Sarawak General Hospital and all primary care facilities who were involved in the study. The authors would like to thank the Director General of Health Malaysia for permission to publish this manuscript.

Funding

The study was funded by a grant from the National Institutes of Health, Ministry of Health, Malaysia.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alan Yean Yip Fong.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yeo, J.J.P., Yeo, L.S., Tan, S.S.N. et al. Prevalence of true resistant hypertension in those referred for uncontrolled hypertension in Malaysia: A comparison using different definitions. Hypertens Res 47, 352–357 (2024). https://doi.org/10.1038/s41440-023-01418-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41440-023-01418-4

Keywords

This article is cited by

Search

Quick links